| Dr Aaron James Cutler, OD | |
|
900 Aaron Dr, Apt 121, Richland, WA 99352-4628 | |
| (509) 371-9012 | |
| Not Available |
| Full Name | Dr Aaron James Cutler |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | 900 Aaron Dr, Richland, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649429788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD60039348 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shoptikal Llc | 1456684471 | 162 |
News Archive
To the list of oncogenic drivers of lung cancer that includes ALK, EGFR, ROS1 and RET, results of a University of Colorado Cancer Center study presented at ASCO 2013 show that mutations in the gene NTRK1 cause a subset of lung cancers.
Ethel Sylvester dialed 911, trembling with fear. The 92-year-old felt hot. She thought turning off her thermostat could fix the problem. That didn't help.
Karen Roberto and Tina Savla, both core faculty members of Virginia Tech's Center for Gerontology, are leading a five-year, $2.14 million study that will examine the role of extended family caregivers and their service use, needs, and challenges.
Pharmaceutical scientists typically face a meager five percent success rate for anti-cancer drugs in clinical trials. To help improve this success rate, Japanese scientists, led by Dr. Tetsuya Terasaki, one of the top pharmaceutical scientists focused on drug transporters, have developed a new approach designed to overcome complexities of developing new, more effective drugs to treat diseases, including cancer.
› Verified 4 days ago
| Provider Name | Shoptikal Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154987535 PECOS PAC ID: 1456684471 Enrollment ID: O20190708001493 |
News Archive
To the list of oncogenic drivers of lung cancer that includes ALK, EGFR, ROS1 and RET, results of a University of Colorado Cancer Center study presented at ASCO 2013 show that mutations in the gene NTRK1 cause a subset of lung cancers.
Ethel Sylvester dialed 911, trembling with fear. The 92-year-old felt hot. She thought turning off her thermostat could fix the problem. That didn't help.
Karen Roberto and Tina Savla, both core faculty members of Virginia Tech's Center for Gerontology, are leading a five-year, $2.14 million study that will examine the role of extended family caregivers and their service use, needs, and challenges.
Pharmaceutical scientists typically face a meager five percent success rate for anti-cancer drugs in clinical trials. To help improve this success rate, Japanese scientists, led by Dr. Tetsuya Terasaki, one of the top pharmaceutical scientists focused on drug transporters, have developed a new approach designed to overcome complexities of developing new, more effective drugs to treat diseases, including cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron James Cutler, OD 900 Aaron Dr, Apt 121, Richland, WA 99352-4628 Ph: (509) 371-9012 | Dr Aaron James Cutler, OD 900 Aaron Dr, Apt 121, Richland, WA 99352-4628 Ph: (509) 371-9012 |
News Archive
To the list of oncogenic drivers of lung cancer that includes ALK, EGFR, ROS1 and RET, results of a University of Colorado Cancer Center study presented at ASCO 2013 show that mutations in the gene NTRK1 cause a subset of lung cancers.
Ethel Sylvester dialed 911, trembling with fear. The 92-year-old felt hot. She thought turning off her thermostat could fix the problem. That didn't help.
Karen Roberto and Tina Savla, both core faculty members of Virginia Tech's Center for Gerontology, are leading a five-year, $2.14 million study that will examine the role of extended family caregivers and their service use, needs, and challenges.
Pharmaceutical scientists typically face a meager five percent success rate for anti-cancer drugs in clinical trials. To help improve this success rate, Japanese scientists, led by Dr. Tetsuya Terasaki, one of the top pharmaceutical scientists focused on drug transporters, have developed a new approach designed to overcome complexities of developing new, more effective drugs to treat diseases, including cancer.
› Verified 4 days ago
Dale D Heaston, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1321 Aaron Dr, Richland, WA 99352 Phone: 509-943-3171 Fax: 509-946-0905 | |
Daniel Plesha, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1321 Aaron Dr, Richland, WA 99352 Phone: 509-943-3171 | |
Brandon Spencer Furness, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 112 Columbia Point Dr, Ste 102, Richland, WA 99352 Phone: 509-943-6565 Fax: 509-946-6416 | |
Jannet L. Calvert Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 214 Torbett St Ste A, Richland, WA 99354 Phone: 509-946-1999 Fax: 509-946-9969 | |
Elizabeth Heaston Thompson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1321 Aaron Dr, Richland, WA 99352 Phone: 509-943-3171 Fax: 509-946-0905 | |
Dr. Jannet L Calvert, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 214 Torbett St Ste A, Richland, WA 99354 Phone: 509-946-1999 Fax: 509-946-9969 | |
Dr. Jason Thomas Hair, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2170 Keene Rd, Richland, WA 99352 Phone: 509-402-2399 Fax: 509-260-8895 |